TCTAP 2014

Johnson & Johnson Medical Korea Ltd.

Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the medical marketplace and the needs of patients have made Cordis the world's leading developer and manufacturer

Johnson & Johnson Medical Korea Ltd. 24F LS Yongsan tower, 191 Hangangro-2Ga, yongsan-Gu, Seoul, Kor
+82-2-2094-3500
http://www.jnjmed.co.kr

Booth No. E029

Exhibition Item
ADROIT PTCA Guiding Catheter
SMART Self Expanding Peripheral Stent
EMPIRA & EMPIRA NC PTCA Balloon
Exoseal Vascular Closure Device

Satellite Symposium

Save the Leg Project 2014: Road to Success for Complex PAD Patients - Learning from Professionals
Organized by CVRF and Supported by Educational Grant from Johnson & Johnson Medical Korea and Japan
Wednesday, April 23 12:45 PM - 1:45 PM Coronary Arena, Level 1
Moderator(s): Donghoon Choi, Kazushi Urasawa
Panelist(s): Masahiko Fujihara, Kentaro Jujo, Su Hong Kim, Ung Kim, Seung-Whan Lee

12:45 PM	Opening Remarks Speaker : Donghoon Choi
12:46 PM	Lesson 1: Overcoming the Challenges - Various Approaches & Strategies for Super Complex Lesions Lecturer : Kazushi Urasawa
1:01 PM	Lesson 2: Strategy for Success in CLI - Common Challenging Scenarios and Solutions Lecturer : Jae-Hwan Lee
1:16 PM	Lesson 3: Updating the Overview of the Worldwide Evidences Lecturer : Osamu Iida
1:34 PM	Discussion and Q & A
1:44 PM	Closing Remarks Speaker : Kazushi Urasawa